News & Events

New Capital Strengthens ProtaGene's Advanced Analytical Leadership in the Biologics and Cell and Gene Therapy Markets

Meeting the Growing Need for Advanced Analytical Services

ProtaGene Appoints New Scientific and Commercial Leadership to Support Evolving Needs of Biologic and Cell and Gene Therapy Innovators

Thanks for a Successful 2022

Now Offering: Integration Site Analysis in the US

ProtaGene Names Pharmaceutical Industry Leader Raymond Kaiser as Chief Executive Officer to Drive Next Stages of Growth 

New Advanced Analytics Lab in North America

We Are Saddened to Report the Passing of Dr. Manfred Schmidt

FierceBio: New CRO ProtaGene to target Analytics Demand; Plans for US Testing Facility

Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene

Protagen Protein Services Merges with GeneWerk to Integrate Leading Protein and Gene Therapy Analytic Platforms

Protagen Protein Services and BioAnalytix Merge to Create Global Analytic Service Partner for Biopharmaceuticals